ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hormonas hipofisarias e hipotalámicas y análogos - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
Unión Europea -
español -
EMA (European Medicines Agency)